Hep C - ClinicalTrials.gov - Information on Clinical Trials and Human Research
ClinicalTrials.gov - Information on Clinical Trials and Human Research
1. Recruiting Reasons for Non-Treatment of Hepatitis C in HCV Mono-Infected Patients Versus HCV-HIV Co-Infected Patients in a University Setting Conditions
Hemophilia, HIV, Hepatitis C HCV Lawsuit: 2006 Update
Hemophiliacs around the world have filed lawsuits in the United States courts against American manufacturers for allegedly selling blood factor contaminated with HIV and/or Hepatitis C (HCV
Sex and HCV
What is the Prevalence of HCV in Persons at Risk for Sexually Transmitted Diseases? In U.S. seroprevalence studies conducted among sex workers, persons attending STD
HCV Abstracts & Publications : ViraCor Laboratories
HCV-Related Kidney Disease After Kidney Transplantation. Abstract # 576. American Transplant Congress 2003. This study examined the outcomes of HCV positive recipients receiving an HCV positive or
Hepatitis C Selected Articles
New HCV Drug Tarvacin, an 'anti-phosphotidylserine mmunotherapeutic' - (02/28/06) AASLD: Safety & Efficacy of Schering HCV Protease Inhibitor + Peg-Intron for Genotype 1 Non-responders to

<< Home